Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Colchicine Lodoco Agepha Pharma price cost

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible, an executive with Agepha Pharma told Cardiovascular Business. 

radiologist radiology pay compensation money dollar

Radiologist is the highest paying job in these 4 states

Those include the nation’s most populace state, which employs 1,700 members of the specialty earning $339,140 annually. 

Thumbnail

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

breast cancer mammography mammogram

FDA approves Bayer’s imaging agent Ultravist for use in contrast-enhanced mammography

The Germany-based corporation said this is the “only contrast agent approved for this indication” in America. 

Thumbnail

American College of Radiology voices support for MD tapped to lead NIH amid confirmation hearing holdup

“We must not lose momentum," ACR, the Academy for Radiology & Biomedical Imaging Research and more than 100 other organizations wrote to leaders of the U.S. Senate. 

artificial intelligence anxiety excitement

Anxiety edging out excitement over our AI-everywhere future: Survey

Americans are somewhat more troubled than thrilled over AI’s mounting presence in modern life. But the collective outlook is a rich blend of both.

china news

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment.

Cardiologists applaud FDA’s approval of colchicine for CVD

"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug.